TLR8-dependent TNF-α overexpression in Fanconi anemia group C cells

Blood

Volumn 114, Issue 26, 2009, Pages 5290-5298

  Vanderwerf, Scott M ^a   Svahn, Johanna ^b   Olson, Susan ^c   Rathbun, R Keaney ^d,e   Harrington, Christina ^a,c   Yates, Jane ^d,e   Keeble, Winifred ^d,e   Anderson, David C ^f   Anur, Praveen ^g   Pereira, Noemi F ^h   Pilonetto, Daniela V ^h   Pasquini, Ricardo ^h   Bagby, Grover C ^c,d,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b G GASLINI INSTITUTE   (Italy)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e PORTLAND VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF OREGON   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INTERLEUKIN 1 RECEPTOR; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; FANCONI ANEMIA GROUP C PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; FANCONI ANEMIA; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; ANIMAL; BIOSYNTHESIS; DNA MICROARRAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOPRECIPITATION; METABOLISM; MONONUCLEAR CELL; MOUSE MUTANT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPRECIPITATION; LEUKOCYTES, MONONUCLEAR; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINATION; UP-REGULATION;

EID: 73949118736     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-222414     Document Type: Article

References (47)

1. de Winter JP, Joenje H. The genetic and molecular basis of Fanconi anemia. Mutat Res. 2009;668(1-2):11-19
2. Pang Q, Christianson TA, Keeble W, et al. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Blood. 2001;98(5):1392-1401.
3. Bagby GC. Genetic basis of Fanconi anemia. Curr Opin Hematol. 2003;10(1):68-76.
4. Bijangi-Vishehsaraei K, Saadatzadeh MR, Werne A, et al. Enhanced TNF-α-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1. Blood. 2005;106(13):4124- 4130.
5. Pang Q, Keeble W, Diaz J, et al. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA. Blood. 2001;97(6):1644-1652.
6. Pang Q, Keeble W, Christianson TA, Faulkner GR, Bagby GC. FANCC interacts with hsp70 to protect hematopoietic cells from IFNγ/TNFα-mediated cytotoxicity. EMBO J. 2001;20(16):4478-4489.
7. Pang QS, Christianson TA, Keeble W, Koretsky T, Bagby GC. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J Biol Chem. 2002;277(51):49638-49643.
8. Zhang XL, Li J, Sejas DP, Rathbun KR, Bagby GC, Pang QS. The Fanconi anemia proteins functionally interact with the protein kinase regulated by RNA (PKR). J Biol Chem. 2004;279(42):43910-43919.
9. Li J, Sejas DP, Zhang X, et al. TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. J Clin Invest. 2007;117:3283-3295.
10. Schultz JC, Shahidi NT. Tumor necrosis factoralpha overproduction in Fanconi's anemia. Am J Hematol. 1993;42:196-201.
11. Dufour C, Corcione A, Svahn J, et al. TNFα and IFNγ are overexpressed in the bone marrow of Fanconi anemia patients and TNFα suppresses erythropoiesis in vitro. Blood. 2003.15;102(6):2053-2059.
12. Rosselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor α. Blood. 1994;83:1216-1225.
13. Sejas DP, Rani R, Qiu Y, et al. Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice. J Immunol. 2007;178(8):5277-5287.
14. Zhang X, Sejas DP, Qiu Y, Williams DA, Pang Q. Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence. J Cell Sci. 2007;120(9):1572-1583.
15. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7(2):249-262.
16. Smogorzewska A, Matsuoka S, Vinciguerra P, et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell. 2007;129:289-301.
17. Shimamura A, Montes DO, Svenson JL, et al. A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood. 2002;100(13):4649-4654.
18. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol. 1993;21:731-733.
19. Pearl-Yafe M, Halperin D, Scheuerman O, Fabian I. The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. Biochem Pharmacol. 2004;67(3):539-546.
20. Rathbun RK, Faulkner GR, Ostroski MH, et al. Inactivation of the Fanconi anemia group C (FAC) gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood. 1997;90:974-985.
21. Gururaja T, LiW, Noble WS, Payan DG,Anderson DC. Multiple functional categories of proteins identified in an in vitro cellular ubiquitin affinity extract using shotgun peptide sequencing. J Proteome Res. 2003;2(4):394-404.
22. Gururaja T, LiW, Bernstein J, Payan DG,Anderson DC. Use of MEDUSA-based data analysis and capillary HPLC-ion-trap mass spectrometry to examine complex immunoaffinity extracts of RBAp48. J Proteome Res. 2002;1(3):253-261.
23. Anderson DC, Li W, Payan DG, Noble WS. A new algorithm for the evaluation of shotgun peptide sequencing in proteomics: support vector machine classification of peptide MS/MS spectra and SEQUEST scores. J Proteome Res. 2003;2(2):137-146.
24. Pejovic T, Yates JE, Liu HY, et al. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res. 2006;66(18):9017-9025.
25. Pang Q, Fagerlie S, Christianson TA, et al. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Mol Cell Biol. 2000;20(13):4724-4735.
26. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol. 2006;43(3):147-156.
27. Carpenter S, O'Neill LA. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J. 2009;422(1):1-10.
28. Cohn MA, D'Andrea AD. Chromatin recruitment of DNA repair proteins: lessons from the Fanconi anemia and double-strand break repair pathways. Mol Cell. 2008;32(3):306-312.
29. Li X, Yang Y, Yuan J, et al. Continuous in vivo infusion of interferon-gamma (IFN-γ) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wildtype cells in Fancc-/- mice. Blood. 2004;104:1204-1209.
30. Fagerlie SR, Diaz J, Christianson TA, et al. Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes. Blood. 2001;97(10):3017-3024.
31. Koh PS, Hughes GC, Faulkner GR, Keeble WW, Bagby GC. The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-α and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily. Exp Hematol. 1999;27(1):1-8.
32. Pigullo S, Ferretti E, Lanciotti M, et al. Human Fanconi A cells are susceptible to TRAIL-induced apoptosis. Br J Haematol. 2007;136(2):315-318.
33. Whitney MA, Royle G, Low MJ, et al. Germ cell defects and hematopoietic hypersensitivity to g-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood. 1996;88:49-58.
34. Haneline LS, Broxmeyer HE, Cooper S, et al. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from FAC-/- mice. Blood. 1998;91:4092-4098.
35. Dufour C, Corcione A, Svahn J, Haupt R, Battilana N, Pistoia V. Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia. Br J Haematol. 2001;115(4):1023-1031.
36. Briot D, Macé-Aimé G, Subra F, Rosselli F. Aberrant activation of stress-response pathways leads to TNF-α oversecretion in Fanconi anemia. Blood. 2008;111(4):1913-1923.
37. Cao W, Bao C, Padalko E, Lowenstein CJ. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J Exp Med. 2008;205(6):1491-1503.
38. Cecil AA, Klemsz MJ. p38 activation through Toll-like receptors modulates IFN-gamma-induced expression of the Tap-1 gene only in macrophages. J Leukoc Biol. 2004;75(3):560-568.
39. Hosoi T, Suzuki S, Nomura J, et al. Bacterial DNA induced iNOS expression through MyD88-p38 MAP kinase in mouse primary cultured glial cells. Brain Res Mol Brain Res. 2004;124(2):159-164.
40. Gorden KB, Gorski KS, Gibson SJ, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol. 2005;174(3):1259-1268.
41. Rajagopal R, Waller AS, Mendoza JD, Wightman PD. The covalent modification and regulation of TLR8 in HEK-293 cells stimulated with imidazoquinoline agonists. Biochem J. 2008;409(1):275-287.
42. Bhoj VG, Chen ZJ. Ubiquitylation in innate and adaptive immunity. Nature. 2009;458(7237):430-437.
43. O'Neill LA. Primer: Toll-like receptor signaling pathways - what do rheumatologists need to know? Nat Clin Pract Rheumatol. 2008;4(6):319-327.
44. Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16(1):3-9.
45. Wang J, Shao Y, Bennett TA, Shankar RA, Wightman PD, Reddy LG. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J Biol Chem. 2006;281(49):37427-37434.
46. Heyninck K, Beyaert R. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci. 2005;30(1):1-4.
47. Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430(7000):694-699.